21st September 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

*Refresh the page if the below document does not appear.

India to play host to drug regulators of 46 Nations

Pharmexcil (Pharmaceutical Export Promotion Council) is hosting Global Regulators Conclave at India Expo Centre in Noida from September 21-23. The participating drug regulators majorly hail from Africa, South America, CIS region, and parts of Asia.

Indian Healthcare industry holds second highest rank in cyber crime attacks over the world

According to CloudSEK’s (Cyber security intelligence) firm report, India reported the highest number of cyber attacks after US, with a total of 7.7% of the total attacks on the healthcare industry in 2021.

Zydus pharma launches Lenalidomide Capsules in US market

The Company had received final approval earlier this month for 5 mg, 10 mg, 15 mg and 25 mg dose and tentative approval for 2.5mg and 20mg dose Capsules.

Pharma stocks lifts Indian shares by 1%

Indian stocks because of a surge in Pharma stocks rose 1% on Tuesday in broad-based buying. There was 1.1% rise in NSE Nifty 50 index (.NSEI) to ₹17,816.25 and a 0.98% rise in S&P BSE Sensex (.BSESN) that stopped at ₹59,719.74.

Haleon rejects compensation plea from GSK and Pfizer for Zantac

Haleon had sent a rejection notification to GSK and Pfizer related to their requests for indemnification with respect to the US based case over Zantac (allegedly containing carcinogenic properties).

US FDA designates Antengene's ATG-101 as an Orphan drug

The leading global biopharmaceutical company announced that its indegeneously developed novel PD-L1/4-1BB bispecific antibody has received an ODD (Orphan Drug Designation) by the US regulatory body for the treatment of pancreatic cancer.

GENFIT to acquire Versantis with $109 Million deal

The US-based biopharma company, GENFIT will be able access the Swiss clinical-stage biotech company Versantis’ main asset VS-01, a liposomal-based drug candidate for the treatment of acute-on-chronic liver failure (ACLF) and urea cycle disorder (UCD).

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Update profile

Please update your profile to keep using the website

Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?